Ningjing Lin

A safe and potent anti-CD19 CAR T cell therapy

Zhitao Ying, Xue F. Huang, Yanling Liu et al. · Nature Medicine · 2019 · 447 citations · Full text

Life Sciences, Cell Biology, Immunology +10

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

Zhitao Ying, Ting He, Xiaopei Wang et al. · Molecular Therapy — Oncolytics · 2019 · 167 citations · Full text

Medicine, Immunology, Oncology +16

Glioblastoma Multiforme Oncogenomics and Signaling Pathways

Okezie Obasi Kanu, Betsy D. Hughes, Chunhui Di et al. · Clinical medicine Oncology · 2009 · 143 citations · Full text

Medicine, Cancer Biology, Oncology +17

L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type

Weiben Yong, Wen Zheng, Jun Zhu et al. · Annals of Hematology · 2008 · 114 citations

Veterinary Medicine, Oncology, Immunotherapy +5

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin

Lijuan Deng, Yuqin Song, Ken H. Young et al. · Oncotarget · 2015 · 97 citations · Full text

Medicine, Oncology, Pathology +15